Valvular heart disease
Conditions
Interventions
OPEP group:2-3 days before cardiac surgery, the training will be carried out with oscillating positive expiratory pressure (OPEP). The oscillating frequency will be set at 10Hz, the expiratory pressur
OPEP placebo group:2-3 days before cardiac surgery, the sham training will be carried out with oscillating positive expiratory pressure (OPEP). No training parameters will be set. 10 breathing cycles
Control group:Absence of OPEP training
Sponsors
Department of Rehabilitation Medicine, West China Tianfu Hospital, Sichuan University
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: (1) Agreement of receiving cardiac surgery; (2) NYHA grade:?/?/?; (3) Cognitively normal and able to cooperate with the study; (4) Sign the agreement of the informed consent and participation in this study.
Exclusion criteria
Exclusion criteria: (1) Unstable angina; (2) Patients with aortic dissection; (3) Heart transplantation; (4) Age < 18 years old; (5) Nerve/muscle/skeletal diseases affecting the training of patients; (6) Preoperative mechanical circulatory support (extracorporeal membrane oxygenation, aortic balloon counterpulsation, ventricular assistance devices) was required; (7) Received respiratory training or rehabilitation training within 8 weeks; (8) Previous history of thoracotomy surgery; (9) Surgery-related complications require reoperation; (10) Re-admission to ICU; (11) Recent surgery or trauma to the face, mouth or skull; (12) Recent esophageal surgery; (13) Active hemoptysis; (14) Acute sinusitis; (15) Untreated pneumothorax; (16) Known or suspected tympanic membrane rupture or other middle ear disease; (17) Uncontrolled severe arrhythmias that cause symptoms or hemodynamic disturbances; (18) Combined with serious physical disease and uncorrected clinical conditions (such as severe anemia, electrolyte disorders, and hyperthyroidism); (19) Participants in other clinical trials at the same time; (20) Patients who are uncooperative or unable to communicate; (21) Expected survival of less than 6 months; (22) Death during hospitalization.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Postoperative pulmonary complications;Pulmonary function; | — |
Secondary
| Measure | Time frame |
|---|---|
| Quality of life;Adverse event;Hospitalization expenses; | — |
Countries
China
Contacts
Public ContactJia Chengsen
Department of Rehabilitation Medicine, West China Tianfu Hospital, Sichuan University
Outcome results
None listed